Study guide

17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

IJCAHPO Certified Ophthalmic Medical Technologist COMT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements

1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification

2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology

2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway

3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety

3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety

4 Chapter 4: Ophthalmic History Taking & Clinical Documentation

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record

5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision

5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction

6 Chapter 6: Tonometry, Keratometry & Pupil Measurement

6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria

7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis

7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment

8 Chapter 8: Refraction, Retinoscopy & Refinement

8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations

9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics

9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations

10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy

10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training

11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation

11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing

12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique

12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics

13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols

13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials

14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)

14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics

15 Chapter 15: Fluorescein Angiography Principles & Technique

15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management

16 Chapter 16: Angiographic Interpretation & Pathology

16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology

17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

18 Chapter 18: Ophthalmic Photography & Videography

18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management

19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)

19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging

20 Chapter 20: Biometry, Topography & Corneal Analysis

20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting

21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems

22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications

22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

23 Chapter 23: Ocular Pharmacology

23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF

24 Chapter 24: Microbiology & Ocular Specimen Collection

24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection

25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery

25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs

26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery

26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol

27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)

28 Chapter 28: Ophthalmic Patient Services & Education

28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support

29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance

29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements

17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

Key Takeaways Explain This Topic AI

OCT Angiography (OCTA) detects intravascular blood flow without dye injection by calculating decorrelation signals between consecutive B-scans acquired at the identical retinal coordinate.

Split-Spectrum Amplitude-Decorrelation Angiography (SSADA) divides the full OCT spectrum into narrower sub-bands to suppress axial bulk motion artifacts while preserving transverse capillary resolution.

OCTA volumetrically segments chorioretinal vasculature into four standardized slabs: Superficial Retinal Capillary Plexus, Deep Retinal Capillary Plexus, Avascular Outer Retina, and Choriocapillaris.

Normal outer retina is completely avascular; abnormal flow signals in this slab indicate choroidal neovascularization (Type 2 CNV or Type 3 RAP lesions).

Key quantitative OCTA biomarkers include Foveal Avascular Zone (FAZ) area and circularity, vessel density (VD), and non-perfusion area, which are vulnerable to projection, motion, and segmentation artifacts.

Last updated: September 2026

Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

Clinical Core: Optical Coherence Tomography Angiography (OCTA) delivers non-invasive, depth-resolved, three-dimensional angiograms of retinal and choroidal microvascular networks. By isolating motion contrast from red blood cell flux across repeated B-scans, OCTA eliminates dye injection risks while resolving individual capillary plexuses—superficial, deep, and choriocapillaris—that overlap and blur on conventional fluorescein angiography.

Physical Principles of OCT Angiography (OCTA)

Conventional dye-based angiography (FA and ICGA) captures two-dimensional, time-resolved planar images of dye transit, filling, and leakage. However, FA cannot differentiate the superficial capillary bed from the deep capillary bed because the fluorescein signal from multiple depths is integrated onto a single sensor plane. Furthermore, dye leakage and pooling obscure fine capillary details in macular edema and neovascularization.

Motion Contrast & Decorrelation Imaging

OCTA generates vascular contrast by using the patient's own circulating erythrocytes (red blood cells) as intrinsic contrast agents:

Sequential B-Scan Acquisition: The OCT scanner rapidly acquires multiple consecutive B-scans (typically 2 to 4 repeated B-scans) at the exact same transverse retinal coordinate within a brief time interval (e.g., 5 milliseconds).

Static vs. Dynamic Tissue:

Static Structural Tissues: Retinal layers without blood flow (e.g., nuclear layers, plexiform layers, sclera) exhibit consistent optical backscattering over time. Their backscattered light waves retain identical amplitude and phase.

Dynamic Intravascular Lumens: Erythrocytes moving through capillaries, arterioles, and venules constantly change position. Consequently, the backscattered light wave exhibits temporal fluctuations in amplitude , phase , or both.

Decorrelation Signal: Software algorithms calculate the pixel-by-pixel difference—the decorrelation —between sequential scans. Areas with high decorrelation are mapped as perfused blood vessels, while static tissues with near-zero decorrelation are rendered black.

The SSADA Algorithm & Complex Decorrelation

Bulk ocular motion (e.g., microsaccades, cardiac pulse, respiration) causes unwanted global phase shifts that can overwhelm capillary signals:

Split-Spectrum Amplitude-Decorrelation Angiography (SSADA): Developed by Jia, Huang, and colleagues, SSADA splits the wide spectral bandwidth of the OCT signal into multiple smaller, overlapping spectral sub-bands. It calculates amplitude decorrelation within each individual sub-band and averages them. Because splitting the spectrum broadens the coherence length in the axial direction, SSADA dramatically reduces sensitivity to axial bulk motion noise without degrading transverse capillary resolution.

Complex Decorrelation / Optical Microangiography (OMAG): Other platforms utilize both amplitude and phase information (complex decorrelation) or full-spectrum algorithms combined with hardware eye-trackers to maximize capillary sensitivity.

Segmentation Slabs & Anatomical Vascular Networks

OCTA software automatically segments the volumetric retinal dataset into anatomically defined parallel slabs bounded by structural OCT interfaces. The standard clinical slabs include: +-----------------------------------------------------------------------------------+

  • | OCTA ANATOMICAL SEGMENTATION SLABS |
  • +-----------------------------------------------------------------------------------+
  • | 1. SUPERFICIAL RETINAL CAPILLARY PLEXUS (SCP) |
  • | Boundaries: Internal Limiting Membrane (ILM) to IPL / INL junction |
  • | Anatomy: Located in RNFL & GCL; centripetal linear capillaries; feed arterioles|
  • +-----------------------------------------------------------------------------------+
  • | 2. DEEP RETINAL CAPILLARY PLEXUS (DCP) |
  • | Boundaries: IPL / INL junction to OPL / ONL junction |
  • | Anatomy: Located in INL & OPL; polygonal lobular meshwork; site of PAMM |
  • +-----------------------------------------------------------------------------------+
  • | 3. AVASCULAR OUTER RETINA |
  • | Boundaries: OPL / ONL junction to Bruch's Membrane |
  • | Anatomy: Normally ZERO flow signal; flow confirms Type 2 CNV or Type 3 RAP |
  • +-----------------------------------------------------------------------------------+
  • | 4. CHORIOCAPILLARIS SLAB |
  • | Boundaries: 10 - 30 µm slab immediately below Bruch's Membrane |
  • | Anatomy: Dense continuous capillary meshwork; flow voids indicate ischemia |
  • +-----------------------------------------------------------------------------------+
  • 1. Superficial Retinal Capillary Plexus (SCP)

Anatomical Localization: Extends from the ILM down to the boundary between the Inner Plexiform Layer (IPL) and Inner Nuclear Layer (INL).

Vascular Architecture: Occupies the nerve fiber layer and ganglion cell layer. Composed of terminal arterioles, venules, and interconnected linear capillary networks arranged in a radiating, centripetal pattern around the foveal avascular zone. In the peripapillary region, this slab includes the radial peripapillary capillary (RPC) plexus, which runs parallel to nerve fiber bundles.

2. Deep Retinal Capillary Plexus (DCP)

Anatomical Localization: Spans from the IPL/INL boundary down to the junction between the Outer Plexiform Layer (OPL) and Outer Nuclear Layer (ONL).

Vascular Architecture: Localized primarily within the inner nuclear layer and outer plexiform layer. Characterized by a dense, polygonal, lobular capillary network arranged in converging star-like or vortex patterns around central draining venules. The DCP consists purely of capillaries, lacking muscularized arterioles.

Vulnerability to Ischemia: Because of its distal position in retinal hemodynamics, the DCP is exceptionally susceptible to microvascular hypoperfusion. Ischemic infarction of the DCP results in Paracentral Acute Middle Maculopathy (PAMM) , which manifests on structural OCT as a hyperreflective band at the level of the INL and on OCTA as profound deep capillary dropout.

3. Avascular Outer Retina

Anatomical Localization: Sliced from the OPL/ONL boundary down to the outer surface of Bruch's membrane (encompassing the photoreceptor inner/outer segments and outer nuclear layer).

Normal Physiology: In a healthy eye, this anatomical compartment contains no blood vessels; the normal decorrelation signal is zero (completely dark) .

Pathological Neovascularization: Any detectable decorrelation flow signal in this slab is pathognomonic for pathological neovascularization:

Type 2 Choroidal Neovascularization (Classic CNV): Neovascular vessels that have breached Bruch's membrane and the RPE, proliferating in the subretinal space.

Type 3 Neovascularization (Retinal Angiomatous Proliferation / RAP): Intraretinal telangiectatic neovascular tufts originating from the deep capillary plexus that dive downward into the avascular outer retina toward the RPE.

4. Choriocapillaris Slab

Anatomical Localization: A thin 10 to 30 µm slab positioned immediately below the hyperreflective Bruch's membrane complex.

Vascular Architecture: Appears as a dense, homogeneous, granular capillary sheet with microscopic intercapillary spaces.

Clinical Biomarkers: Evaluated for flow voids (areas of signal dropout) reflecting choriocapillaris hypoperfusion or atrophy in geographic atrophy, diabetic choroidopathy, systemic hypertension, and inflammatory chorioretinopathies (e.g., APMPPE, MEWDS). This slab is also essential for delineating Type 1 (Occult) CNV , which proliferates within the sub-RPE space above Bruch's membrane.

Quantitative OCTA Biomarkers

Automated software algorithms extract objective, reproducible metrics to track microvascular disease progression and response to anti-VEGF pharmacotherapy.

Quantitative Biomarker Definition & Normal Reference Values Clinical Significance & Disease Correlations

Foveal Avascular Zone (FAZ) Area Central capillary-free zone bounded by inner retinal capillary rings. Normal superficial FAZ: 0.25 – 0.40 mm² ; deep FAZ: 0.35 – 0.50 mm² Enlarges in diabetic macular ischemia (DMI), retinal vein occlusions, and sickle cell maculopathy due to terminal capillary drop-out

FAZ Acircularity / Circularity Index Mathematical ratio of FAZ perimeter to area compared to a perfect circle (normal circularity ratio: 0.70 – 0.85 ) Decreases significantly as the smooth, circular capillary ring becomes irregular, notched, or fragmented in early diabetic microangiopathy

Vessel Density (VD) Percentage of measured area occupied by skeletonized or binarized functional blood vessels (normal macular VD: 45% – 55% ) Quantifies capillary dropout; serves as a sensitive biomarker for diabetic retinopathy severity, macular branch vein occlusion, and glaucoma

Perfusion Density Percentage of total area covered by perfused vascular pixels on thresholded binarized en-face scans Highly reproducible metric of microvascular perfusion; tracks capillary recovery or loss during anti-VEGF or panretinal laser therapy

Non-Perfusion Area (NPA) Automated total area (in mm²) of capillary non-perfusion within the macular scan Quantifies regional macular ischemia; correlates with visual acuity loss and risk of neovascular proliferation

OCTA Image Artifacts & Troubleshooting Strategies

Because OCTA relies on motion contrast and automated segmentation, images are highly prone to unique artifacts that can mimic pathology or conceal true lesions.

1. Bulk Motion Artifacts

Cause: Patient microsaccades, tremor, breathing, or head shifts cause rapid global displacement of retinal tissue between consecutive B-scans.

Appearance: Appears as bright white or dark black horizontal transverse stripes across the en-face angiogram, accompanied by horizontal vessel displacement or "shearing" defects.

Troubleshooting: Ensure active eye-tracking is locked on the iris/retinal features; utilize orthogonal dual-volume acquisition (fast-X and fast-Y scans) which merges horizontal and vertical raster volumes to cancel motion vectors; instruct the patient to fixate firmly on the target.

2. Projection Artifacts

Cause: Fluctuating shadows cast by moving erythrocytes in the superficial retinal capillary plexus pass through deeper hyperreflective structures—specifically the RPE and outer plexiform layer. The fluctuating shadow alters the backscattered light phase and amplitude, creating a false decorrelation signal in the deeper slabs.

Appearance: Duplicated "ghost" copies of superficial large vessels and capillaries appear falsely projected onto the deep capillary plexus, avascular outer retina, and choriocapillaris slabs.

Troubleshooting: Activate Projection-Resolved OCTA (PR-OCTA) software algorithms, which mathematically compare the decorrelation value of deeper pixels with the overlying superficial pixels and remove identical vessel patterns from the deeper slabs.

3. Segmentation Errors

Cause: Distortions of normal retinal anatomy by pathology—such as cystoid macular edema (CME), large pigment epithelial detachments (PEDs), subretinal fluid, or severe vitreomacular traction—cause the automated algorithm to place slab boundary lines at the wrong anatomical depth.

Appearance: Non-vascular tissue (e.g., fluid cysts) or out-of-plane vessels (e.g., superficial vessels captured in the deep slab) distort the angiogram, creating pseudo-flow voids or false vascular networks.

Troubleshooting: The technologist must inspect the cross-sectional B-scans with color-coded segmentation lines; access the manual segmentation editor; and manually reposition the boundary lines to follow true anatomical layers.

4. Shadow / Signal Attenuation Artifacts

Cause: Dense optical media—such as intraretinal hemorrhages, hard exudates, dense vitreous floaters (asteroid hyalosis), or dense cataracts—absorb and scatter OCT light, preventing light from reaching underlying vascular beds.

Appearance: Appears as a well-circumscribed patch of complete flow absence (pseudo-non-perfusion) in the deep capillary plexus and choriocapillaris.

Troubleshooting: Cross-reference the OCTA en-face angiogram with the corresponding structural OCT B-scan and reflectance image. If the area of absent flow matches a hyperreflective shadow-casting opacity, the defect is a shadow artifact rather than true vascular non-perfusion.

Loading diagram... OCTA Systematic Slab Analysis and Artifact Elimination Protocol